Quality nucleusPharmaceutical Manufacturing
Sterile ophthalmics, oral solid dosage, pharmaceutical packaging, facility commissioning, qualification, and technology-transfer readiness.
Founder leadership
More than 20 years connecting regulated pharmaceutical and medical-device manufacturing with patient-centered pharmacy operations in Pakistan and the United Arab Emirates.
Ahmed Zafar, RPh.
Registered Pharmacist · Founder & CEO
Misbah Healthcare (Private) Limited
Ahmed Zafar, RPh., is a registered pharmacist and manufacturing professional with more than two decades of multidisciplinary experience across pharmaceutical production, sterile medical-device manufacturing, production and operations management, and UAE community-pharmacy practice.
From 2003 to 2008 at Schazoo Zaka, his work progressed through sterile ophthalmic manufacturing, oral solid dosage, and pharmaceutical packaging. His responsibilities included aseptic and cleanroom operations, tablets, capsules, sachets, in-process controls, BMR/BPR execution, line clearance, reconciliation, equipment qualification, and manufacturing readiness.
From 2009 to 2015 at Lahore Medical Instruments, he supported and then managed production of sterile disposable syringes and infusion giving sets across injection molding, tubing extrusion, assembly, blister packaging, and EtO sterilization in cGMP and ISO 13485-aligned operations.
From 2015 to 2025 in Sharjah, he served as In-Charge Pharmacist at Bab Al Hikma Pharmacy and Pharmacist at Al Washah Pharmacy, combining dispensing and patient counselling with team leadership, inventory, procurement, supplier coordination, insurance workflows, documentation, and customer service.
As Founder and Chief Executive Officer, he applies this end-to-end perspective to Misbah Healthcare’s product, manufacturing, distribution, private-label, regulatory, and digital-health pathways, with quality, evidence, ethics, and patient safety as decision controls.
“Quality without compromise, innovation with purpose, and healthcare with integrity.”
Professional background
Leadership Across the Healthcare Value Chain
Medical-Device Operations
Production leadership for sterile syringes and infusion sets, including molding, extrusion, assembly, blister packaging, cleanroom controls, and EtO sterilization.
Community-Pharmacy Leadership
Ten years across in-charge and pharmacist roles covering safe dispensing, patient counselling, teams, inventory, procurement, insurance workflows, and operational compliance.
Quality and Process Systems
cGMP operations, ISO 13485-aligned systems, cleanrooms, BMR/BPR control, validation, qualification, CAPA awareness, OEE, TPM, and continuous process improvement.
This summary reflects founder-supplied professional history in the CV and publicly indexed LinkedIn information. Historical licence and evaluation references do not represent independent confirmation of current authorization or any corporate certification.
Evidence of execution
Selected Operational Contributions
Representative projects were selected for their relevance to Misbah Healthcare’s planned manufacturing, quality, supplier, and operational pathways.
Sterile and oral-dosage manufacturing
Executed and supervised sterile ophthalmic manufacturing, then led oral solid dosage and packaging operations covering tablets, capsules, sachets, line clearance, reconciliation, in-process control, and batch documentation.
Plant commissioning and technology transfer
Participated in commissioning and start-up of a pharmaceutical facility, including equipment qualification, production readiness, and process transfer for tablets, capsules, and sachets.
EtO validation and process improvement
Contributed to validation of a previously non-validated ethylene-oxide sterilization process, qualification of two sterilizers, and a time-motion study across nine manual infusion-set assembly processes.
“At Misbah Healthcare, our goal is to develop healthcare opportunities through scientific discipline, appropriate quality controls, and responsible partnerships. Whether evaluating a medical-device pathway or a future pharmacy service, patient safety must remain the ultimate decision criterion.”
— Ahmed Zafar